Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Cowen Group
0
Cowen Group
Suggest edits
Overview
News
Investments
6
Portfolio
Portfolio Tracker
Add info
FinSMEs
Orchard Therapeutics Prices Initial Public Offering
Stock markets
Health
Costs
$200,000,000
IPO
PE Hub
,
FinSMEs
VC-backed Orchard Therapeutics goes public
Stock markets
TechCrunch
Livongo Health expands under new offering with Abbott Labs
Health
Cloud
$150,000,000
Venture capital (Series C)
FinSMEs
Orchard Therapeutics Raises $150M in Series C Financing
Funding
Health
$75,000,000
IPO
PE Hub
VC-backed Kezar Life Sciences unveils IPO
Stock markets
Health
Acquisition
Xconomy
Livongo Health Grows with Purchase of Weight Loss Startup Retrofit
Health
$105,000,000
Venture capital (Series E)
MedCity News
,
Forbes
,
Xconomy
Livongo rakes in $105M, introduces partnership with Cambia Health Solutions
GeekWire
,
FinSMEs
Cambia Health and Livongo partner to bring personal, tech-driven diabetes program to Pacific Northwest
Health
Funding
$110,000,000
Venture capital (Series B)
PE Hub
| Gene therapy developer Orchard Therapeutics raises $110 million: Reuters
Health
Funding
Xconomy
MyoKardia Heart Drug Boosts Blood Flow, Sends Shares Soaring
Health
Private equity
Reuters
CEFC China to buy 20 percent stake in U.S. brokerage Cowen
Venture capital
FinSMEs
Semma Therapeutics Raises Additional Funding
$52,500,000
Venture capital (Series D)
TechCrunch
,
VentureBeat
,
e27
Smart diabetes management service Livongo Health raises $52.5M and looks to new markets
Health
People
PE Hub
Livongo Health rakes in $52.5 mln
Funding
Messaging
Data leaks
$20,000,000
Grant
FierceBiotech
Orchard gets $20M to trial ‘bubble boy’ gene therapy
$5,000,000
Grant
FinSMEs
,
businesswire
Semma Therapeutics Receives $5M Grant from California Institute of Regenerative Medicine
£21,000,000
Venture capital (Series A)
b3cnewswire
Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies
$44,500,000
Venture capital (Series C)
FinSMEs
Livongo Health Completes $44.5M Series C Financing
Health
Funding
Xconomy
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations
Health
Stock markets
Xconomy
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO
Health
Funding
